United Capital Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,169
| Closed | -$702K | – | 1093 |
|
|
2022
Q4 | $702K | Sell |
6,169
-616
| -9% | -$70.1K | ﹤0.01% | 693 |
|
|
2022
Q3 | $420K | Sell |
6,785
-8,766
| -56% | -$543K | ﹤0.01% | 799 |
|
|
2022
Q2 | $1.24M | Buy |
15,551
+10,953
| +238% | +$873K | 0.01% | 590 |
|
|
2022
Q1 | $484K | Sell |
4,598
-104
| -2% | -$10.9K | ﹤0.01% | 835 |
|
|
2021
Q4 | $507K | Buy |
4,702
+187
| +4% | +$20.2K | ﹤0.01% | 852 |
|
|
2021
Q3 | $495K | Sell |
4,515
-96
| -2% | -$10.5K | ﹤0.01% | 858 |
|
|
2021
Q2 | $432K | Sell |
4,611
-270
| -6% | -$25.3K | ﹤0.01% | 905 |
|
|
2021
Q1 | $449K | Sell |
4,881
-189
| -4% | -$17.4K | ﹤0.01% | 873 |
|
|
2020
Q4 | $371K | Buy |
5,070
+924
| +22% | +$67.6K | ﹤0.01% | 928 |
|
|
2020
Q3 | $322K | Buy |
4,146
+210
| +5% | +$16.3K | ﹤0.01% | 934 |
|
|
2020
Q2 | $219K | Buy |
+3,936
| New | +$219K | ﹤0.01% | 1071 |
|
|
2017
Q3 | – | Sell |
-37,009
| Closed | -$439K | – | 1352 |
|
|
2017
Q2 | $439K | Sell |
37,009
-97,952
| -73% | -$1.16M | ﹤0.01% | 961 |
|
|
2017
Q1 | $2M | Buy |
134,961
+20,198
| +18% | +$299K | 0.02% | 574 |
|
|
2016
Q4 | $1.86M | Buy |
114,763
+11,689
| +11% | +$189K | 0.02% | 582 |
|
|
2016
Q3 | $1.87M | Sell |
103,074
-1,265
| -1% | -$22.9K | 0.02% | 605 |
|
|
2016
Q2 | $1.67M | Sell |
104,339
-2,785
| -3% | -$44.5K | 0.02% | 596 |
|
|
2016
Q1 | $1.78M | Buy |
+107,124
| New | +$1.78M | 0.02% | 564 |
|